Literature DB >> 24855615

Two-year outcomes of deep brain stimulation in adults with cerebral palsy.

Ae Ryoung Kim1, Jin Woo Chang2, Won Seok Chang2, Eun Sook Park1, Sung-Rae Cho3.   

Abstract

OBJECTIVE: To investigate the effect of deep brain stimulation (DBS) on reducing dystonia and disability in adults with cerebral palsy (CP) and to compare the therapeutic outcomes between primary dystonia patients and CP patients over two years after bilateral pallidal DBS.
METHODS: Five patients with primary dystonia and seven CP patients with dystonia were recruited. All subjects received DBS surgery in both globus pallidus. Burke-Fahn-Marsden dystonia rating scale consisting of dystonia movement score and disability score and subjective satisfaction scale were assessed after 1 month and every 6 months over two years following DBS treatment.
RESULTS: On the dystonia movement scale, both groups of primary dystonia patients and CP patients showed a significant decrease over time following DBS. On the disability scale, patients with primary dystonia showed a significant decrease over time, whereas the disability score of CP patients did not change over the two years. Comparing the dystonia movement and disability scores of CP patients at each assessment, patients with primary dystonia showed a significant reduction after 6 months. Comparing the satisfaction scores of CP patients after DBS, patients with primary dystonia showed significantly higher subjective satisfaction.
CONCLUSION: Whereas dystonia can be significantly reduced in patients with primary dystonia, CP patients showed a modest improvement on the dystonia movement scale, but not on the disability scale. Therefore, DBS may be considered with caution as a treatment modality of CP patients with dystonia.

Entities:  

Keywords:  Cerebral palsy; Deep brain stimulation; Dystonia; Dystonia rating scale

Year:  2014        PMID: 24855615      PMCID: PMC4026607          DOI: 10.5535/arm.2014.38.2.209

Source DB:  PubMed          Journal:  Ann Rehabil Med        ISSN: 2234-0645


  26 in total

Review 1.  Dystonia: medical therapy and botulinum toxin.

Authors:  Joseph Jankovic
Journal:  Adv Neurol       Date:  2004

Review 2.  Neurosurgical interventions in the treatment of idiopathic Parkinson disease: neurostimulation and neural implantation.

Authors:  A Kupsch; C Earl
Journal:  J Mol Med (Berl)       Date:  1999-01       Impact factor: 4.599

3.  Deep brain stimulation for movement and other neurologic disorders.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Ann N Y Acad Sci       Date:  2012-07-23       Impact factor: 5.691

4.  From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.

Authors:  P Krack; P Pollak; P Limousin; A Benazzouz; G Deuschl; A L Benabid
Journal:  Brain       Date:  1999-06       Impact factor: 13.501

Review 5.  The role of deep brain stimulation as a surgical treatment for Parkinson's disease.

Authors:  C W Olanow; M F Brin; J A Obeso
Journal:  Neurology       Date:  2000       Impact factor: 9.910

6.  Bilateral globus pallidus internus deep brain stimulation for DYT1+ generalized dystonia with previously received bilateral thalamotomy and unilateral pallidotomy.

Authors:  Joo Pyung Kim; Won Seok Chang; Young Seok Park; Jin Woo Chang
Journal:  Stereotact Funct Neurosurg       Date:  2011-05-20       Impact factor: 1.875

Review 7.  The treatment of movement disorders by deep brain stimulation.

Authors:  Hong Yu; Joseph S Neimat
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  Deep brain stimulation for secondary dystonia: results in 8 patients.

Authors:  P F Katsakiori; Z Kefalopoulou; E Markaki; A Paschali; J Ellul; G C Kagadis; E Chroni; C Constantoyannis
Journal:  Acta Neurochir (Wien)       Date:  2009-03-26       Impact factor: 2.216

9.  A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes.

Authors:  Theresa E Pretto; Arif Dalvi; Un Jung Kang; Richard D Penn
Journal:  J Neurosurg       Date:  2008-09       Impact factor: 5.115

Review 10.  The physiological effects of pallidal deep brain stimulation in dystonia.

Authors:  Stephen Tisch; John C Rothwell; Patricia Limousin; Marwan I Hariz; Daniel M Corcos
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2007-06       Impact factor: 3.802

View more
  6 in total

Review 1.  Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review.

Authors:  Amogh Kudva; Mickey E Abraham; Justin Gold; Neal A Patel; Julian L Gendreau; Yehuda Herschman; Antonios Mammis
Journal:  Neurosurg Rev       Date:  2021-04-19       Impact factor: 3.042

Review 2.  Movement disorders due to bilirubin toxicity.

Authors:  Jessica Rose; Rachel Vassar
Journal:  Semin Fetal Neonatal Med       Date:  2014-12-16       Impact factor: 3.926

3.  Report of a workshop on research gaps in the treatment of cerebral palsy.

Authors:  Codrin Lungu; Deborah Hirtz; Diane Damiano; Paul Gross; Jonathan W Mink
Journal:  Neurology       Date:  2016-08-24       Impact factor: 9.910

4.  Thalamic deep brain stimulation for acquired dystonia in children and young adults: a phase 1 clinical trial.

Authors:  Marta San Luciano; Amy Robichaux-Viehoever; Kristen A Dodenhoff; Melissa L Gittings; Aaron C Viser; Caroline A Racine; Ian O Bledsoe; Christa Watson Pereira; Sarah S Wang; Philip A Starr; Jill L Ostrem
Journal:  J Neurosurg Pediatr       Date:  2020-11-27       Impact factor: 2.375

5.  Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury.

Authors:  Young Kwon Yoon; Kil Chan Lee; Han Eol Cho; Minji Chae; Jin Woo Chang; Won Seok Chang; Sung-Rae Cho
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 6.  The Symptomatic Treatment of Acquired Dystonia: A Systematic Review.

Authors:  Corina N A M van den Heuvel; Marina A J Tijssen; Bart P C van de Warrenburg; Cathérine C S Delnooz
Journal:  Mov Disord Clin Pract       Date:  2016-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.